Trump who also tweeted the deal shook Sons hand and posed for photos, reveling as he had last week when he toured a Carrier plant in Indiana where he said he had instigated an agreement that will preserve about 1,000 jobs the appliance maker had planned to move to Mexico. Details of the deal were scarce and it was unclear if the money was part of a fund of up to $100 billion in global technology investments that SoftBank and the government of Saudi Arabia announced in October. As for Air Force One, the government has agreed that Boeing will build two new planes, which would go into service around 2024. That means Trump might never fly on the aircraft, which carry U.S. presidents around the globe. The Air Force has pressed for a faster schedule, saying the aging current Boeing 747s are becoming too expensive to repair and keep in good flying shape. why not look hereThe overall deal for researching, developing and building new planes was to be about $3 billion, but costs have been reported to be rising. The General Accountability Office estimated in March that about $2 billion of the total for work between 2010 and 2020 was for research and development on complex systems, not for building the actual aircraft. The inflated $4 billion figure Trump cited appears to include operation and maintenance as well. SEE ALSO Trump rips Boeing for ‘out of control’ cost of new Air Force One Boeing responded to Trump Tuesday in a statement : We are currently under contract for $170 million to help determine the capabilities of these complex military aircraft that serve the unique requirements of the president of the United States.special info
For the original version including any supplementary images or video, visit http://nypost.com/2016/12/06/trump-compares-defending-us-jobs-to-war-during-thank-you-tour/
His research interests focus on the exploration of the link between skin barrier dysfunction and systemic allergic disorders, threshold doses of food allergens, immunomodulation of established allergic responses, prevention of allergic sensitization, and evaluation of quality of life in food allergic children. He is co-principal investigator for the BASELINE birth cohort study, which is tracking more than 2,000 Irish children from soon after conception over several years to study the effects of intrauterine growth restriction, the incidence and prevalence of food allergy and eczema in early childhood, and the incidence and effects of maternal and infant vitamin D status on growth and health. He was Founding Secretary of the Irish Association of Allergy and Immunology and is Founding Chairman of the Irish Food Allergy Network. Dr. Hourihane earned his Bachelor of Medicine (M.B.), Bachelor of Surgery (B.Ch.), and Bachelor of Obstetrics (B.A.O.) degrees at Dublin University, Trinity College and an M.D. from the University of Southampton. Stacie M. Jones, M.D., is a Professor of Pediatrics and Chief of Allergy and Immunology at the University of Arkansas for Medical Sciences and Arkansas Children’s Hospital. She is also a researcher at the Arkansas Children’s Research Institute. Her research focuses on both clinical and translational investigation of food allergy and eosinophilic gastrointestinal disorders, as well as on asthma and lung disease.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/aimmune-therapeutics-appoints-scientific-advisory-120000190.html
You may also be interested to read
- his response
- click to read more
- try this website